1

Expansion of Antimicrobial Resistance Surveillance (AMR) in Tanzania (Expand AMR)

John Lusingu

NIMR Tanga

Global Health Protection Programme (GHP)

€400,000

03/2023 to 02/2026

2

Strengthening environmental surveillance to advance public health action

Vito Baraka

NIMR Tanga

EDCTP3

€525,800.00

04/2023 to 03/2026

3

Severe Malaria treatment with Rectal artesunate and Artemisinin-based Combination Therapy [in remote settings]. (Acronym: SEMA ReACT).

Vito Baraka

NIMR Tanga

EDCTP3

€231,645.00

04/2023 to 03/2027

4

Climate Change and its Adverse Effects on the double burden of Malnutrition and Infectious Diseases among women of reproductive age in northeastern Tanzania

Daniel Minja

NIMR Tanga

Danida

DKK 3,000,000

01/2024 to 12/2027

5

Building resilient research ethics, Diagnostics and medicines regulatory capacity during routine and public health emergency periods (BREEDIME).

Elias Nyanda

NIMR Mbeya/NIMR Muhimbili

EDCTP3

€ 599 637.50.

1st June 2023 – 31st May 2026

6

A Phase IIb, Open-Label, Randomized Controlled Dose Ranging Multi-Centre Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Exposure-Response Relationship of different doses of BTZ-043 in combination with Bedaquiline and Delamanidin in Adult Subjects with Newly Diagnosed, Uncomplicated, Drug-sensitive Pulmonary Tuberculosis (DECISION Trial)

Lilian T Minja

NIMR Mbeya

The German Ministry for Education and Research (BMBF) and The Innovative Medicines Initiative (IMI)

€ 12,000 per patient

2023- 2025

7

Medical and Environmental Anthropology for 21st Century East Africa

Peter Mangesho

NIMR Amani

NORAD

Norwegian Krone 20,000,000

Jan 2021 – Dec 2026.

8

Entomological evaluation by pool screening (o-150 PCR) to demonstrate the interruption of onchocerca volvulus transmission in stopping of ivermectin mass drug administration

Akili Kalinga

NIMR Headquarters

African Field Epidemiology Network (AFENET/CDC)

Jan 2021–Dec 2025

9

Evaluation of OV16 ELISA serological prevalence of ≤2% in stopping mass drug administration (MDA) in Onchocerciasis elimination

Akili Kalinga

NIMR Headquarters

AFENET/CDC

$ 112,000

Jan 2021–Dec 2025

10

Suspected artemisinin resistance in Africa: Tracking its Emergence and Evolution in Tanzania, Rwanda, Uganda, and the Democratic Republic of Congo

Deus Ishengoma

NIMR Headquarters

National Institute of Health

$121,825

2021-2025

11

Decentralized sequencing for infectious disease surveillance in Tanzania [SEQ-TZ]

Lucas Matemba

NIMR Dodoma

DANIDA

TZS 4,158,537

2021–2025

12

Implementation of Hydrocele Surgeries in Tanzania

Lucas Matemba

NIMR Dodoma

ENDFUND Foundation

TZS 38,078,110

2022-2024

13

The National Malaria Vector Entomology Surveillance (MVES)

William Kisinza

NIMR Amani

Ministry of Health, Tanzania NMCP

TZS 1,209,262,880.00

2023 – 2025

14

Insecticidal efficacy, physical degradation and fabric integrity of the standard pyrethroid long lasting insecticide treated nets (LLINs) and new generation (Piperonyl

William Kisinza

NIMR Amani

Global fund through Ministry of Health, Tanzania NMCP

TZS. 120,960,000.00

Jan 2023 – Dec 2024.